Aus dem Institut für Immunologie und Transfusionsmedizin der Universität zu Lübeck Direktor: Prof. Dr. med. H. Kirchner Das Hepatitis B-Virus in der Transfusionsmedizin Inauguraldissertation zur Erlangung der Doktorwürde der Universität zu Lübeck - Aus der Medizinischen Fakultät - Vorgelegt von Ines Puchta aus Hoyerswerda Lübeck 2006
76
Embed
Das Hepatitis B-Virus in der Transfusionsmedizin · HBV Hepatitis B-Virus HCV Hepatitis C-Virus ... Struktur des HBV (23) Das komplette Virus wird nach seinem ... D ist in Südeuropa,
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Aus dem Institut für Immunologie und Transfusionsmedizin
der Universität zu Lübeck
Direktor: Prof. Dr. med. H. Kirchner
Das Hepatitis B-Virus in der Transfusionsmedizin
Inauguraldissertation
zur
Erlangung der Doktorwürde
der Universität zu Lübeck
- Aus der Medizinischen Fakultät -
Vorgelegt von
Ines Puchta
aus Hoyerswerda
Lübeck 2006
2
1. Berichterstatter: Priv.-Doz. Dr. med. H. Hennig
1. Albin C und Robinson WS. Protein Kinase activity in Hepatitis B virus. J Virol. 34: 297- 302. 1980.
2. Alexopoulou A, Baltayiannis G, Jammeh S, Waters J, Dourakis SP und Karayiannis P. Hepatitis B Surface Antigen Variant with Multiple Mutations in the a Determinant in an Agammaglobulinemic Patient. J Clin Microbiol. 42: 2861- 2865. 2004.
3. Alhababi F, Sallam TA und Tong WT. The significance of "anti-HBc only" in the clinical virology laboratory. J Clin Virol. 27: 162- 169. 2003.
5. Allain JP, Hewitt PE, Tedder RS und Williamson LM. Evidence that anti-HBc but not HBV DNA testing may prevent some HBV transmission by transfusion. Brit J Haematol. 107: 186- 195. 1999.
6. Almeida JD, Rubenstein D und Scott EJ. New Antigen-Antibody System in Australia-Antigen-Positive Hepatitis. Lancet. 1225- 1227. 1971.
7. Alter HJ und Blumberg BS. Further Studies on a "New" Human Isoprecipitin System (Australia Antigen). Blood. 27: 297- 309. 1966.
8. Aufgestellt gemäß Transfusionsgesetz von der Bundesärztekammer im Einvernehmen mit dem Paul-Ehrlich-Institut. Richtlinien zur Gewinnung von Blut und Blutbestandteilen und zur Anwendung von Blutprodukten (Hämotherapie). Gesamtnovelle 2005. Kapitel 2: Ausschluß von der Blutspende. S. 17. Deutscher Ärzteverlag. 2005.
9. Bancroft WH, Mundo FK und Russel PK. Detection Of Additional Antigenic Determinants Of Hepatitis B Antigen. J Immunol. 109: 842- 848. 1972.
10. Bang NU, Ruegsegger P, Ley AB und LaDue JS. Detection of Hepatitis Carriers by Serum Glutamic Oxalacetic Transaminase Activity. JAMA. 171: 2303- 2306. 1959.
11. Basuni AA, Butterworth L, Cooksley G, Locarnini S und Carman WF. Prevalence of HBsAg mutants and impact of hepatitis B infant immunisation in four Pacific Island countries. Vaccine. 22: 2791- 2799. 2004.
12. Bayer ME, Blumberg BS und Werner B. Particles associated with Australia Antigen in the Sera of Patients with Leukemia, Down`s syndrome and Hepatitis. Nature. 218: 1057- 1059. 1968.
13. Beeson BP. Jaundice Occuring One To Four Months After Transfusion Of Blood Or Plasma. JAMA. 1332- 1334. 1943.
66
14. Beld M, Habibub MR, Rebers SP, Boom R und Resenink HW. Evaluation of automated RNA-extraction technology and a qualitative HCV assay for sensitivity and detection of HCV RNA in pool screening systems. Transfusion. 40: 575- 579. 2000.
15. Bhat RA, Ulrich P, Vyas PPU und Vyas GN. Molecular Characterization of a New Variant of Hepatitis B Virus in a Persistently Infected Homosexual Man. Hepatol. 11: 271- 276. 1990.
16. Blum HE, Liang TJ, Galun E, und Wands JR. Persistence of Hepatitis B Viral DNA After Serological recovery from Hepatitis Virus Infection. Hepatol. 14: 56- 63. 1990.
17. Blum HE, Offensperger WB, Offensperger S und Gerok W. Latent hepatitis B virus infection with full-length viral genome in a patient serologically immune to hepatitis B virus infection. Liver. 8: 307- 316. 1988.
18. Blumberg BS, Alter HJ und Visnich S. A "New" Antigen in Leukemia Sera. JAMA. 191: 541- 546. 1965.
19. Blumberg BS, Gerstley BJS, Hungerford DA, London WT und Sutnick AL. A Serum Antigen (Australia Antigen) in Down´s Syndrom Leukemia and Hepatitis. Ann Intern Med. 66: 924- 931. 1967.
20. Boom R, Sol CJA, Salimans MMM, Jansen CL, Wertheim-van Dillen PME und van der Noordaa J. Rapid and Simple Method for Purification of Nucleic Acids. J Clin Microbiol. 28: 495- 503. 1990.
21. Brechot C, Degos F, Lugassy C, Thiers V, Zafrani S, Franco D, Bismuth H, Trepo C, Benhamou JP, Wands J, Isselbacher K, Tiollais P und Berthelot P. Hepatitis B Virus DNA In Patients With Chronic Liver Disease And Negative Tests For Hepatitis B Surface Antigen. N Engl J Med. 312: 270- 276. 1985.
22. Burger R, Offergeld R. Erhöhung der Sicherheit von zellulären Blutkomponenten und quarantänegelagertem Frischplasma durch Untersuchungen der Blut- und Plasmaspenden auf Antikörper gegen Hepatitis-B-Core-Antigen (Anti-HBc). Bundesgesundheitsbl-Gesundheitsforsch-Gesundheitsschutz. 48: 698-699. 2005.
23. Burger R, Gerlich W Gürtler L, Heiden M, Hitzler W, Jansen B, Kretschmer V, Lefevre H, Löwer H, Ludwig WD, Montag-Lessing T, Neumann R, Paessens A, Pauli G, Seitz R, Schlenkrich U, Werner E und Willkommen H. Hepatitis-B-Virus (HBV) Stellungnahmen des Arbeitskreises Blut des Bundesministerium für Gesundheit. Bundesgesundheitsbl-Gesundheitsforsch-Gesundheitsschutz 3. 43: 240- 248. 2000.
24. Busch MP. Should HBV NAT replace HBsAg and/or anti-HBc screening of blood donors. Transfus Clin Biol. 26- 32. 2004.
67
25. Carman WF, Zanetti AR, Karayiannis P, Waters J, Manzillo G, Tanzi E, Zuckermann AJ und Thomas HC. Vaccine- induced escape mutant of hepatitis B virus. Lancet. 336: 325- 329. 1990.
26. Caspari G, Beyer HJ, Elbert G, Koerner K, Muss P, Schunter FW, Uy A, Gerlich W, Thomssen R und Schmitt H. Unsatisfactory Specificities and Sensitivities of Six Enzyme Immunoassays for Antibodies to Hepatitis B Core Antigen. J Clin Microbiol. 27: 2067- 2972. 1989.
27. Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW und Houghton M. Isolation of a cDNA Clone Derived from a Blood Born Non-A, Non-B Viral Hepatitis Genome. Science. 244: 359- 362. 1989.
28. Coleman PF, Chen YCK und Mushawar IK. Immunoassay Detection of Hepatitis B Surface Antigen Mutants. J Med Virol. 59: 19- 24. 1999.
29. Colgrove R, Simon G und Ganem D. Transcriptional Activation of Homologous and Heterologous Genes by the Hepatitis B Virus X Gene Product in Cells Permissive for Viral Replication. J Virol. 63: 4019- 4026. 1989.
30. Coorman MP, Leroux-Roels G und Paulij WP. Vaccine- and hepatitis B immun globulin-induced escape mutations of hepatitis B virus surface antigen. J Biomed Sci. 8: 237- 247. 2001.
31. Dai MS, Kao WY, Shyu RY und Chao TY. Restoration of immunity and reactivation of hepatits B virus after immunosuppressive therapy in a patient with aplastic anaemia. J Viral Hepatitis. 11: 283- 285. 2004.
32. Damesyn MA, Glynn SA, Schreiber GB, Ownby HE, Bethel J, Fridey J, McMullen Q, Garraty G und Busch MP. Behavior and infectious desease risks in young blood donors: implications for recruitment. Transfusion. 43: 1596- 1603. 2003.
33. Dane DS, Cameron CH und Briggs M. Virus-Like Particles In Serum Of Patients With Australia-Antigen-Associated Hepatitis. Lancet. 695- 698. 1970.
34. De Feo TM, Poli F, Mozzi F, Moretti MP, Scalamogna M und Collaborative Kidney, Liver and Heart North Italy Transplant Program Study Groups. Risk of transmission of hepatitis B virus from anti-HBc positive cadaveric organ donors: a collaborative study. Transplant Proc. 37: 1238- 1239. 2005.
35. Delort AM, Duplaa AM, Molko D und Teoule R. Excision of uracil residues in DNA: mechanism of action of Escherichia coli and Micrococcous luteus uracil- DNA glycosylase. Nucleic Acids Res. 13: 319- 335. 1985.
36. Descos B, Scotto J, Fayol V, Huet JY, Pichoud C, Hermier M, Ville G, Charvet F, Dargent D, Thoulon JM und Trepo C. Anti-HBc Screening for the Prevention of Perinatal Transmission of Hepatitis B Virus in France. Infection. 15: 434- 439. 1992.
68
37. Dhedin N, Douvin C, Kuentz M, Saint Marc MF, Reman O, Rieux C, Bernaudin F, Norol F, Cordonnier C, Bobin D, Metreau JM und Vernant JP. Reverse Seroconversion Of Hepatitis B After Allogeneic Bone Marrow Transplantion. A Retrospective Study Of 37 Patients With Pretransplant Anti-HBs and Anti-HBc. Transplantation. 66: 616- 619. 1998.
38. Dickson RC, Everhart JE, Lake JR, Wei Y, Seaberg EC, Wiesner RH, Zettermann RK, Pruett TL, Ishitani MB, Hoofnagel JH und The National Institut Of Diabetes, Digestive And Kidney Desease Liver Transplantation Database. Transmission of Hepatitis B by Transplantation of Livers From Donors Positive for Antibody to Hepatitis B Core Antigen. Gastroenterology. 113: 1668- 1674. 1997.
39. Dodson SF, Issa S, Araya V, Gayowski T, Pinna A, Eghtesad B, Iwatsuki S, Montalvo E, Rakela J und Fung JJ. Infectivity Of Hepatic Allografts With Antibodies To Hepatitis B Virus. Transplantation. 64: 1582- 1584. 1997.
40. Donahue JG, Munoz DVMA, Ness PM, Donald E MD, Brown DE, David H, McAllister HA, Reitz BA, Nelson KE. THE DECLINING RISK OF POST-TRANSFUSION HEPATITIS C VIRUS INFECTION. N Engl J Med. 327: 369- 373. 1992.
41. Douglas DD, Rakela J, Wright TL, Krom RA und Wiesner RH. The Clinical Course of Transplantation-Associated De Novo Hepatitis B Infection in the Liver Transplant Recipient. Liver Transpl Surg. 3: 105- 111. 1997.
42. Elghouzzi MH, Courouce AM, Magnius LO, Lunel F und Lapierre V. Transmission of hepatitis B virus by HBV negative blood transfusion. Lancet. 346: 964- 964. 1995.
43. Feinstone SM, Kapikian AZ, Purcell RH, Alter HJ und Holland PV. Transfusion-Associated Hepatitis Not Due To Viral Hepatitis Type A Or B. N Engl J Med. 292: 767- 770. 1975.
44. Fiordalisi G, Primi D, Tanzi E, Magni E, Incarbone C, Zanetti AR und Cariani E. Hepatitis B Virus C Gene Heterogenity in a Familial Cluster of Anti- HBc Negative Chronic Carriers. J Med Virol. 42: 109- 114. 1994.
45. Förster VT. Zwischenmolekulare Energiewanderung und Fluoreszenz. Annals of Physics (Leipzig). 2: 55- 75. 1948.
46. Gerken G, Goergen B, Meyer zum Büschenfelde KH. Virushepatitis und B- Virusmutanten- Eine neue diagnostische und klinische Herausforderung. Deutsches Ärzteblatt. 47: 2413- 2480. 1994.
47. Gerlich W und Robinson WS. Hepatitis B Virus Contains Protein Attached to the 5´Terminus of Its Complete DNA Strand. Cell. 21: 801- 809. 1980.
69
48. Gerlich WH und Caspari G. Hepatitis virus and the safety of blood donations. J Viral Hepatitis. 6: 6- 15. 1999.
49. Girones R und Miller RH. Mutation Rate of the Hepadnavirus Genome. Virology. 170: 595- 597. 1989.
50. Gomes SA, Yoshida CF und Niel C. Detection Of Hepatitis B Virus DNA In Hepatitis B Surface Antigen-Negative Serum By Polymerase Chain Reaction: Evaluation Of Different Primer Pairs And Conditions. Acta Virology. 40: 133- 138. 1996.
51. Goodnough TL, Shander A und Brecher ME. Transfusion medicine: looking to the future. Lancet. 361: 161- 169. 2003.
52. Gotoh K, Mima S, Uchida T, Shikata T, Yoshizawa K, Irie M und Mizui M. Nucleotide Sequence of Hepatitis B Virus Isolated From Subjects Without Serum Anti- Hepatitis B Core Antibody. J Med Virol. 46: 201- 206. 1995.
53. Goudeau A und Dubois F. Incidence and prevalence of hepatitis B in France. Vaccine. 13: S22- S25. 1995.
54. Grob P. Introduction to epidemiology and risk of hepatitis B. Vaccine. 13: S14- S15. 1995.
55. Grob P, Jilg W, Bornhak H, Gerken G, Gerlich W, Günther S, Hess G, Hüdig H, Kitchen A, Margolis H, Michel G, Trepo C, Will H, Zanetti A und Mushawar I. Serological Pattern " Anti-HBc Alone": Report on a workshop. J Med Virol. 62: 450- 455. 2000.
56. Gross A, Joller-Jemelka HI, Wicki AN und Grob PJ. Der Hepatitis-serologische Befund "Anti-HBc allein", zirkulierende virale DNA und Befund-Interpretation. Schweiz Med Wochenschr. 123: 1193- 1202. 1993.
57. Hall AJ, Winter PD und Wright R. Mortality Of Hepatitis B Virus Positive Blood Donors In England And Wales. Lancet. 1: 91- 93. 1985.
58. He C, Nomura F, Itoga S, Isobe K und Nakai T. Prevalence of vaccine-induced escape mutants of hepatitis B virus in the adult population in China: a prospective study in 176 restaurant employees. J Gastroenterol Hepatol. 16: 1373- 1377. 2001.
59. Heermann KH, Goldman U, Schwartz W, Seyfarth T, Baumgarten H und Gerlich WH. Large Surface Proteins of Hepatitis B Virus Containing the Pre-S Sequence. J Virol. 52: 396- 402. 1984.
60. Heid CA, Stevens J, Livak KJ und Williams PM. Real Time Quantitative PCR. Genom Res. 6: 986- 994. 1996.
61. Hennig H, Dennin RH, Haase D und Kirchner H. HBV-DNA positive findings in HBsAg negative blood donors and patients. Beitr Infusionsther Transfusionsmedizin. 34: 26- 30. 1997.
70
62. Hennig H, Puchta I, Luhm J, Schlenke P, Goerg S und Kirchner H. Frequency and load of hepatitis B virus DNA in first-time blood donors with antibodies to hepatitis B core antigen. Blood. 100: 2637- 2641. 2003.
63. Holland PM, Abramson RD, Watson R und Gelfand DH. Detection and specific polymrease chain reaction product utilizing the 5´-3´exonuclease activity of Thermus aquaticus DNA polymerase. Proc Natl Acad Sci. 88: 7276- 7280. 1991.
64. Hoofnagel JH, Seef LB, Bales ZB, Zimmermann HJ und The Veterans Administration Hepatitis Cooperative Study Group. Type B Hepatitis After Transfusion With Blood Containing Antibody To Hepatitis B Core Antigen. N Engl J Med. 298: 1379- 1383. 1978.
65. Horowitz B, Bonomo R und Prince AM. Solvent/Detergent-Treated Plasma: A Virus-Inactivated Substitute for Fresh Frozen Plasma. Blood. 79: 826- 831. 1992.
66. Hsu HJ, Chang MH, Hsieh KH, Lee CY, Lin HN, Hwang LH, Chen PJ und Chen DS. Cellular Immune Response to HBcAg in Mother-to-Infant Transmission of Hepatitis B Virus. Hepatology. 15: 770- 776. 1992.
67. Jackson BR, Busch MP, Stramer SL und Aubouchon JP. The cost-effectivness of NAT for HIV, HCV and HBV in whole blood donations. Transfusion. 43: 721- 729. 2003.
68. Jilg W. Hepatitis B - Bedeutung für die Transfusionsmedizin. Infusionsther Transfusionsm. 21: 20- 26. 1994.
69. Jilg W, Hottenträger B, Weinberger K, Schlottmann K, Frick E, Holstege A, Schölmerich J und Palitzsch KD. Prevalence of Markers of Hepatitis B in the Adult German Population. J Med Virol. 63: 96- 102. 2001.
70. Jongerius JM, Bovenhorst M, van der Poel CL, van Hilton JA, Kroes ACM, van der Does JA, van Leeuwen EF und Schuurman R. Evaluation of automated nucleic acid extraction devices for application in HCV NAT. Transfusion. 40: 871- 874. 2000.
71. Jung M CH und Pape GR. Virushepatitiden. Deutsches Ärzteblatt 91. 40: 1986- 1992. 1994.
72. Kaneko S, Miller RH, Di Bisceglie AM, Feinstone SM, Hoofnagel JH und Purcell RH. Detection of Hepatitis B Virus DNA in Serum by Polymerase Chain Reaction. Application for clinical diagnosis. Gastroenterolgy. 99: 799- 804. 1990.
73. Kao JH und Ding CS. Global control of hepatitis B virus infection. Lancet Infectious Diseases. 2: 395- 403. 2002.
74. Kaplan PM, Greenman RL Gerin JL, Purcell HR und Robinson WS. DNA Polymerase Associated with Human Hepatitis B Antigen. J Virol. 12: 995- 1005. 1973.
71
75. Kazim SN, Wakil SM, Khan LA, Hasnain SE und Sarin SK. Vertical transmission of hepatitis B despite materna lamivudine therapy. Lancet. 359: 1488- 1489. 2002.
76. Knoll A, Rohrhofer A, Kochanowski B, Wurm EM und Jilg W. Prevalence of precore mutants in anti-HBe-positive hepatitis B virus carriers in Germany. J Med Virol. 59: 14- 18. 2004.
77. Koike K, Shirakata Y, Yaginama K, Arii M, Takada S, Nakamura I, Hayashi Y, Kawada M und Kobayashi M. Oncogenetic Potential of Hepatitis B Virus. Mol Biol Med. 6: 151- 160. 1989.
78. Koziol DE, Holland PV, Alling DW, Melpolder JC, Solomon RE, Purcell RH, Hudson LM, Shoup FJ, Krakauer H und Alter HJ. Antibody to Hepatitis B Core Antigen as a Paradoxical Marker for non-A, non-B Hepatitis Agents on Donated Blood. Ann Intern Med. 104: 488- 495. 1986.
79. Lai CL, Ratziu V, Yuen MF und Poynard T. Viral hepatitis B. Lancet. 362: 2089- 2094. 2003.
80. Larsen J, Hetland G und Skaug K. Posttransfusion hepatitis B transmitted by blood from a hepatitis B surface antigen-negative hepatitis B virus carrier. Transfusion. 30: 431- 432. 1990.
81. Lee JH, Paglieroni TG, Holland PV und Zeldis JB. Chronic Hepatitis B Virus Infection in an Anti-HBc nonreactive Blood Donor: Variant Virus or Defective Immune Response. Hepatology. 16: 24- 30. 1992.
82. Lee LG, Connell CR und Bloch W. Allelic discrimination by nick-translation PCR with fluorogenic probes. Nucleic Acids Res. 21: 3761- 3766. 1993.
83. Livak KJ, Flood SJ, Marmaro J, Giusti W und Deetz K. Oligonucleotides with Flourescent Dyes at Opposite Ends Provide a Quenched Probe System Useful for Detecting PCR Products and Nucleid Acid Hybridization. PCR Methods Applic. 4: 357- 362. 1995.
84. Longo MC, Berniger MS und Hartly JL. Use of uracil DNA glycosylase to control carry-over contamination in polymerase chain reaction. Gene. 93: 125- 128. 1990.
85. Loriot MA, Marcellin P, Bismuth E, Martinot-Peignoux M, Boyer N, Degott C, Erlinger S und Benhamou JP. Demonstration of Hepatitis B Virus DNA by Polymerase Chain Reaction in the Serum and the Liver After Spontaneous or Therapeutically Induced HBeAg to Anti-HBe or HBsAg to Anti-HBs Seroconversion in Patients with Chronic Hepatitis B. Hepatology. 15: 32- 36. 1992.
86. Loriot MA, Marcellin P, Walker F, Boyer N, Degott C, Randrianatoavina I, Benhamou JP und Erlinger S. Persistence of hepatitis B virus DNA in serum and liver from patients with chronic hepatitis B after loss of HBsAg. J Hepatol. 27: 251- 258. 1997.
72
87. Lowell JA, Howard TK, White HM, Shenoy S, Huettner PC, Brennan DC, Peters MG. Serological evidence of past hepatitis B infection in liver donor and hepatitis B infection in liver allograft. Lancet. 345: 1084- 1085. 1995.
88. Marcellin P, Giostra E, Martinot-Peignoux M, Loriot MA, Jaegle ML, Wolf P, Degott C, Degos F und Benhamou JP. Redevelopment of Hepatitis B Surface Antigen After Renal Transplantation. Gastroenterology. 100: 1432- 1434. 1991.
89. Marcellin P, Martinot-Peignoux M, Loriot MA, Giostra E, Boyer N, Thiers V und Benhamou JP. Persistence of Hepatitis B Virus DNA Demonstrated by Polymerase Chain Reaction in Serum and Liver after Loss of HBsAg Induced by Antiviral Therapy. Ann Intern Med. 112: 227- 228. 1990.
90. Margolis HS, Alter MJ und Hadler SC. Hepatitis B: Evolving Epidemiology and Implications for Control. Semin Liver Dis. 11: 84- 92. 1991.
91. Martini GA. Die homologe Serum-Hepatitis. Dtsch med Wschr. 74: 568- 572. 1949.
92. Marusawa H, Imoto S, Ueda Y und Chiba T. Reactivation of latently infected hepatitis B virus in a leukemia patient with antibodies to hepatitis B core antigen. J Gastroenterol. 36: 633- 636. 2001.
93. Marusawa H, Uemoto S, Hijkata M, Ueda Y, Tanaka K, Shimotohno K und Chiba T. Latent Hepatitis B Virus Infection in healthy Individuals With Antibodies to Hepatitis B Core Antigen. Hepatology. 31: 488- 495. 2000.
94. Mason AL, Xu L, Guo L, Kuhns M und Perillo RP. Molecular Basis for Persistence Hepatitis B Virus Infection In The Liver After Clearence of Serum Hepatitis B Surface Antigen. Hepatology. 27: 1736- 1742. 1998.
95. Maynard JE. Hepatitis B: global importance and need for control. Vaccine. 8: S18- S20. 1990.
96. Mei SD, Yatsuhashi H, Parquet M, Hamada R, Fujino T, Matsumoto T, Inoue O, Koga M und Yano M. Detection of HBV RNA in peripheral blood mononuclear cells in patients with and without HBsAg by reverse transcription polymerase chain reaction. Hepatol Res. 18: 19- 28. 2000.
97. Michalak TI, Pasquinelli C, Guilhot S und Chisari FV. Hepatitis B Virus Persistence after Recovery from Acute Viral Hepatitis. J Clin Inves. 94: 230- 239. 1994.
98. Miller RH und Robinson WS. Common evolutionary origin of hepatitis B and retroviruses. Proc Natl Acad Sci. 83: 2531- 2535. 1986.
73
99. Modrow S, Falke D und Truyen U. Molekulare Virologie. 2. Auflage. Kapitel 19.1. Hepadnaviren. 449-469. Spektrum Akademischer Verlag GmbH Heidelberg. Berlin. 2003.
100. Möller B, Hopf U, Stemerowicz R, Henze G und Gelderblom H. HBcAg Expressed on the Surface of Circulating Dane Particles in Patients with Hepatitis B Virus Infection without Evidence of Anti-HBc Formation. Hepatology. 10: 179- 185. 1989.
101. Mosley JW, Stevens CE, Aach RD, Hollinger FB, Mimms LT, Solomon LR, Barbosa LH und Nemo GJ. Donor screening for antibody for hepatitis B core antigen and hepatitis B virus infection in transfusion recipients. Transfusion. 35: 5- 12. 1995.
102. Mullis KB. The Unusual Origin of the Polymerase Chain Reaction. Sci Am. 262: 36- 43. 1990.
103. Ness PM. The broken reimbursement system: putting the brakes on the blood safety train. Transfusion. 43: 1S- 2S. 2003.
104. Nordbo SA, Skaug K, Holter E, Waage A und Brinch L. Reactivation of hepatitis B virus infection in an anti-HBc and anti-HBs positive patient after allogeneic bone marrow transplantation. Eur J Haematol. 65: 86- 87. 2000.
105. Norder H, Hammas B, Larsen J, Skaug K und Magnius LO. Detection of HBV DNA by PCR in serum from an HBsAg negative blood donor implicated in cases of post-transfusion hepatitis B. Arch Virol Suppl. 4: 116- 118. 1992.
106. Offergeld R, Faensen D, Ritter S und Hamouda O. Human immunodefiency virus,hepatitis C and hepatitis B infections among blood donors in Germany 2000-2002, the risk of virus transmission and the impact of NAT testing. Eurosurveillance. 10: 13- 14. 2005.
107. Okochi K und Murakami S. Observations on Australia Antigen in Japanes. Vox Sang. 15: 374- 385. 1968.
108. Pasquetto V, Wieland S und Chisari FV. Intracellular Hepatitis B Virus Nucleocapsids Survive Cytotoxic T-Lymphocyte-Induced Apoptosis. J Virol. 74: 9792- 9796. 2000.
109. Paterlini P, Driss F, Nalpas B, Pisi E, Franco D, Berthelot P und Brechot C. Persistence of Hepatitis B and Hepatitis C Viral Genomes in Primary Liver Cancers from HBsAg-Negative Patients: A Study of a Low-endemic Area. Hepatology. 17: 20- 29. 1993.
110. Prieto M, Gomez M, Berenguer M, Cordoba J, Rayon JM, Pastor M, Garcia-Herola A, Nicolas D, Carassco D, Orbis JF, Mir J und Berenguer J. De Novo Hepatitis B After Liver Transplantation From Hepatitis B Core Antibody-Positive Donors in an Area With High Prevalence of Anti-HBc Positivity in the Donor Population. Liver Transplantation. 7: 51- 58. 2001.
74
111. Prince AM, Lee DH und Brotman B. Infectivity of blood from PCR-positive, HBsAg-negative, anti HBs positive cases of resolved hepatitis B infection. Transfusion. 41: 329- 332. 2001.
112. Rasenack JW, Schlayer HJ, Hettler F, Peters T, Preisler-Adams S und Gerok W. Hepatitis B virus infection without Immunological markers after open-heart surgery. Lancet. 245: 355- 357. 1995.
113. Rehermann B, Ferrari C, Paquinelli C und Chisari FV. The hepatitis B virus persists for decades after patients` recovery from acute viral hepatitis despite active maintance of a cytotoxic T- lymphocyte response. Nat Med. 2: 1104- 1108. 1996.
114. Robertson EF, Wear JA, Randell R, Holland PV, Madsen G und Decker RH. Characterization of a Reduction-Sensitive Factor from Human Plasma Responsible for Apparent False Activity in Competitive Assays for Antibody to Hepatitis B Core Antigen. J Clin Microbiol. 29: 605- 610. 1991.
115. Robinson W, Clayton DA und Greenman RL. DNA of a Human Hepatitis B Virus Candidate. J Virol. 14: 384- 391. 1974.
116. Robinson WS und Greenman RL. DNA Polymerase in the Core of the Human Hepatitis B Virus Candidate. J Virol. 13: 1231- 1236. 1974.
117. Roche B, Samuel D, Gigou M, Feray C, Virot V, Schmets L, David MF, Aralnaden JL, Bismuth A, Reynes M und Bismuth H. De novo and apparent de novo hepatitis B virus infection after liver transplantation. J Hepatol. 26: 517- 526. 1997.
118. Roth WK, Weber M, Petersen D, Drosten C, Buhr S, Sireis W, Weichert W, Hedges D und Seifried E. NAT for HBV and anti-HBc testing increase blood safety. Transfusion. 42: 869- 875. 2002.
119. Roth WK, Weber M und Seifried E. Feasability and efficacy of routine PCR screening of blood donations for hepatitis C virus, hepatitis B virus, and HIV-1 in a bloodbank sitting. Lancet. 353: 359- 363. 1999.
120. Rychlick W, Spencer WJ und Rhoads RC. Optimization of the annealing temperature for DNA amplification in vitro. Nucleic Acids Res. 18: 6409- 6412. 1990.
121. Saiki RK, Gelfand DH, Stoffel S, Scharf SJ, Higuchi R, Horn GT, Mullis KB und Erlich HA. Primer-Directed Enzymatic Amplification of DNA with Thermostable DNA Polymerase. Science. 239: 487- 491. 1988.
122. Saiki RK, Scharf S, Faloona F, Mullis KB, Horn GT, Erlich HA und Arnheim N. Enzymatic Amplification of beta-Globin Genomic Sequences and Restriction Site Analysis for Diagnosis of Sickle Cell Anemia. Science. 230: 1350- 1354. 1985.
75
123. Saldanha J, Gerlich W, Lelie N, Dawson P, Heermann K, Heath A und The WHO Collaborative Study Group. An international collaborative study to establish a World Health Organization international standard for hepatitis B virus DNA nucleid acid amplification techniques. Vox Sang. 80: 63- 71. 2001.
124. Saraswat S, Banerjee K, Chaudhury N, Mahant T, Khandekar P, Gupta RK und Naik S. Post-transfusion hepatitis type B following multiple transfusions of HBsAg-negative blood. J Hepatol. 25: 639- 643. 1996.
125. Sato S, Ohhashi W, Ihara H, Sakaya S, Kato T und Ikeda H. Comparison of the sensitivity of NAT using pooled donor samples for HBV and that of a serologic HBsAg assay. Transfusion. 41: 1107- 1113. 2001.
126. Shikata T. Australia Antigen in Liver Tissue. Japan J Exper Med. 43: 231- 245. 1973.
127. Spandau F und Lee CH. trans-Activation of Viral Enhancers by the Hepatitis B Virus X protein. J Virol. 62: 427- 434. 1988.
128. Stibbe W und Gerlich WH. Structural Relationships Between Minor and Major Proteins of Hepatitis B Surface Antigen. J Virol. 46: 626- 628. 1983.
129. Stoll-Becker S, Repp R, Glebe D, Schaefer S, Kreuder J, Kann M, Lampert F und Gerlich W. Transcription of Hepatitis B Virus in Peripheral Blood Mononuclear Cells from Persistently Infected Patients. J Virol. 71: 5399- 5407. 1997.
130. Struve J, Giesecke J, Lindh G und Weiland O. Utility of an anonymous questionnaire for the identification of a primary transmission route and possible secondary transmission in adults with acute hepatitis B infection. Eur J Epidem. 12: 319- 322. 1996.
131. Sumazaki R, Motz M, Wolf H, Heinig J, Jilg W und Deinhardt F. Detection of Hepatitis B Virus in Serum Using Amplification of Viral DNA by Means of the Polymerase Chain reaction. J Med Virol. 27: 304- 308. 1989.
132. Summers J und Mason WS. Replication of the Genome of a Hepatitis B-Like Virus by Reverse Transcription of an RNA Intermediate. Cell. 29: 403- 415. 1982.
133. Sutnick AI, London WT, Gerstley BJ, Baruch S und Blumberg BS. Anicteric Hepatitis Associated With Australia Antigen. Occurence in Patients with Down`s Syndrom. JAMA. 205: 670- 674. 1968.
134. Thiers V, Nakajima E, Kremsdorf D, Mack D, Schellekens H, Driss F, Goudeau A, Wands J, Sninsky J und Tiollais P. Transmission Of Hepatitis B From Hepatitis-B-Seronegative Subjects. Lancet. 1273- 1276. 1988.
76
135. Tiollais P, Pourcel C und Dejean A. The hepatitis B virus. Nature. 317: 489- 495. 1985.
136. Toh H, Hayashida H und Miyata T. Sequence homology between retroviral reverse transcriptase and putative polymerase of hepatitis B virus and cauliflower mosaik virus. Nature. 305: 827- 829. 1983.
137. Uemoto S, Inomata Yl, Sannomiya A, Koshiba T, Kurokawa T, Takatsuki M, Hino H, Yokoi A und Tanaka K. Posttransplant Hepatitis B Infection in Liver Transplantation With Hepatitis B Core Antibody-Positive Donors. Transplant Proc. 30: 134- 135. 1998.
138. Urban S, Breiner KM, Fehler F, Klingmüller U und Schaller H. Avian Hepatitis B Virus Infection Is Initiated by the Interaction of a Distinct Pre-S-Subdomain with the cellular receptor gp180. J Virol. 72: 8089- 8097. 1998.
139. Wachs ME, Amed WJ, Ascher NL, Bretan PN, Emond J, Lake JR, Melzer JS, Roberts JP, Tomklanovich SJ, Vincenti F und Stock P. The Risk Of Transmission Of Hepatitis B From HBsAg(-), HBcAg(+), HBIgM(-) Organ Donors. Transplantation. 59: 230- 234. 1995.
140. Weber B, Melchior W, Gehrke R, Doerr HW, Berger A und Rabenau H. Hepatitis B Virus Markers in Anti-HBc Only Positive Individuals. J Med Virol. 64: 312- 319. 2001.
141. Wong VC, Ip HM, Reesink HW, Lelie PN, Reerink- Brongers EE, Yeung CY und Ma HK. Prevention of the HBsAg carrier state in newborn infants of mothers who are chronic carriers of HBsAg and HBeAg by administration of hepatitis-B vaccine and hepatitis-B immunoglobulin. Lancet. April: 921- 926. 1984.
142. Yotsuyanagi H, Yasuda K, Lino S, Moriya K, Shintani Y, Fujie H, Tsutsumi T, Kimura S und Koike K. Persistent Viremia After Recovery From Self-Limited Acute Hepatitis B. Hepatology. 27: 1377- 1382. 1998.
143. Yotsuyanagi H, Yasuda K, Moriya K, Shintani Y, Fujie H, Tsutsumi T, Nojiri N, Juji T, Hoshino HS, Himoda K, Hino K, Kimura S, Lino S und Koike K. Frequent presence of HBV in the sera of HBsAg-negative, anti-HBc-positive blood donors. Transfusion. 41: 1093- 1099. 2001.
144. Zervou EK, Dalekos GN, Boumba DS und Tsianos EV. Value of anti-HBc screening of blood donors for prevention of HBV infection: result of a 3-year prospective study in Northwestern Greece. Transfusion. 41: 652- 658. 2001.
145. Zoulim F, Zhang X, Pichoud C und Trepo C. Heterogenity of hepatitis B virus (HBV) core gene in a patient with HBV-associated cirrhosis and serum negativity for anti HBc. J Hepatol. 24: 155- 160. 1996.